Category Medical Research
Drug Targets for Ebola, Dengue, and Zika Viruses Found in Lab Study
Insight into how three of the world's most devastating viruses interact with human cells opens the door for much-needed treatments
Lotus Clinical Research LLC Receives Private Equity Backing
Lotus Clinical Research LLC receives private equity backing; expands team with Jeffrey Kinell and Kurt Brykman joining board of directors
Development of Long-Acting Local Anesthetics
Lotus Clinical Research Presented at Pain Therapeutics in San Francisco on Development of Long-Acting Local Anesthetics
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Three Months Ended 30 September 2018
Parnell delivers 39% revenue growth and a $5.9 million year-to-date improvement in EBITDA as at the third quarter of 2018 compared to the same period in 2017, consolidates the return to profitability, and maintains full-year 2018 guidance at a 35 - 40% increase over 2017 revenue to $26 - $27 million and an EBITDA range of $5.5 - $6.5 million.
Two Young Women Lung Cancer Investigators Receive $200k Research Grants From Lung Cancer Foundation of America and the International Association for the Study of Lung Cancer
Researchers will use IASLC/LCFA funds to create new lung cancer treatments for never-smokers and patients whose cancer has spread
Bioelectronic Medicine: Using Electrical Stimulation to Treat Untreatable Diseases
IDTechEx will be hosting a masterclass on Bioelectronics & Neuroprosthetics at the Santa Clara Convention Center, CA
Vascular Stress Contributes to Age-Associated Vision Loss
$3.6 Million to Study Adverse Effects of Genome Editing
The NIH funds an initiative at the Gladstone Institutes to assess the safety of CRISPR-like therapies in human tissues
OccuPro Research Highlights the Success of OccuPro's Functional Capacity Evaluation
OccuPro's FCE is used for assessing a client's readiness to return to work.
Pipette.com Adds New OHAUS Products to Their Website
International Symposium Convenes to Address Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders
With generous support for research funding, The Ehlers-Danlos Society sponsors International Symposium in Ghent, Belgium, to accelerate collaborative global research into EDS, HSD, their related symptoms and associated conditions.
FARE Clinical Network Adds Vanderbilt University Medical Center as New Center of Excellence
Food Allergy Research & Education's Collaborative to Advance Food Allergy Research Continues to Grow
Two Molecules Offer Great Potential to Combat Cancer and Chronic Infections
Scientists from the Gladstone Institutes discover how to enhance the longevity of cells that kill tumors and infected cells
New Approach to Fight Tuberculosis, a Leading Cause of Death Worldwide
A team of scientists from the Gladstone Institutes, UCSF, and UC Berkeley identify nearly 200 potential drug targets
Dronedarone Promotes Cardiac Repair After a Heart Attack
A New Research Partnership to Find Treatments for Neurological Disorders
BioMotiv and Cure Network Dolby Acceleration Partners collaborate to advance the development of better treatments for brain disorders
A New Environmental Risk Factor for Inflammatory Bowel Disease
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
Jan-Eric Ahlfors, CEO of Fortuna Fix Inc., to present at IABS/CIRM 4th Cell Therapy Conference on June 6, 2018 in Los Angeles
Alterations in Copper Homeostasis in Ischemic Heart Disease
A New Approach for Normalizing Cardiac Arrythmias
Immunotherapy Trials: Overcoming the Challenges of Selecting the Correct Patient Population, New Webinar Hosted by Xtalks
One of America's foremost oncologists leads this webinar series on the past, the present and the future of immunotherapy studies
The Childhood Cancer Project's 100 Keys to the Cure Ultra-Marathon
The Childhood Cancer Project raises $100,000 for childhood cancer research.
